These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25987167)

  • 21. From serendipity to therapy.
    Neufeld EF
    Annu Rev Biochem; 2011; 80():1-15. PubMed ID: 21675915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysosomal storage diseases and the blood-brain barrier.
    Begley DJ; Pontikis CC; Scarpa M
    Curr Pharm Des; 2008; 14(16):1566-80. PubMed ID: 18673198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment for LSDs: no longer just enzyme replacement therapy for Gaucher disease. Foreword.
    Cohen IJ; Baris H; Mistry PK
    Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():58. PubMed ID: 24380122
    [No Abstract]   [Full Text] [Related]  

  • 24. Roscoe Owen Brady, MD: Remembrances of co-investigators and colleagues.
    Desnick RJ; Barton NW; Furbish S; Grabowski GA; Karlsson S; Kolodny EH; Medin JA; Murray GJ; Mistry PK; Patterson MC; Schiffmann R; Weinreb NJ
    Mol Genet Metab; 2017; 120(1-2):1-7. PubMed ID: 27866832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment for Lysosomal Storage Disorders.
    Sheth J; Nair A
    Curr Pharm Des; 2020; 26(40):5110-5118. PubMed ID: 33059565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New strategies for the treatment of lysosomal storage diseases (review).
    Parenti G; Pignata C; Vajro P; Salerno M
    Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysosomes.
    Gieselmann V; Braulke T
    Biochim Biophys Acta; 2009 Apr; 1793(4):603-4. PubMed ID: 19329005
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment for Lsds: real options for several diseases. Forward.
    Cohen IJ; Baris HN; Mistry PK; Sands MS
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():71. PubMed ID: 25345087
    [No Abstract]   [Full Text] [Related]  

  • 29. Lysosomal storage diseases market.
    Werber Y
    Nat Rev Drug Discov; 2004 Jan; 3(1):9-10. PubMed ID: 14756143
    [No Abstract]   [Full Text] [Related]  

  • 30. Biosynthesis of lysosomal proteinases in health and disease.
    Mach L
    Biol Chem; 2002 May; 383(5):751-6. PubMed ID: 12108539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity.
    Fan JQ
    Trends Pharmacol Sci; 2003 Jul; 24(7):355-60. PubMed ID: 12871668
    [No Abstract]   [Full Text] [Related]  

  • 32. Enzyme replacement therapy for lysosomal storage disorders: successful transition from concept to clinical practice.
    Sly WS
    Mo Med; 2004; 101(2):100-4. PubMed ID: 15119106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lysosomal carboxypeptidase A].
    Gacko M; Worowska A; Woźniak A; Jedynak M; Panek B; Lapiński R
    Postepy Biochem; 2005; 51(2):162-70. PubMed ID: 16209354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological small molecules for the treatment of lysosomal storage disorders.
    Smid BE; Aerts JM; Boot RG; Linthorst GE; Hollak CE
    Expert Opin Investig Drugs; 2010 Nov; 19(11):1367-79. PubMed ID: 20942596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzyme replacement therapy and substrate reduction therapy in lysosomal storage disorders with neurological expression.
    Valayannopoulos V
    Handb Clin Neurol; 2013; 113():1851-7. PubMed ID: 23622408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme replacement and enhancement therapies: lessons from lysosomal disorders.
    Desnick RJ; Schuchman EH
    Nat Rev Genet; 2002 Dec; 3(12):954-66. PubMed ID: 12459725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic applications of imino sugars in lysosomal storage disorders.
    Butters TD; Dwek RA; Platt FM
    Curr Top Med Chem; 2003; 3(5):561-74. PubMed ID: 12570866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral small molecule therapy for lysosomal storage diseases.
    Weinreb NJ
    Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():77-90. PubMed ID: 24380126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary biochemical and morphological consequences in lysosomal storage diseases.
    Alroy J; Garganta C; Wiederschain G
    Biochemistry (Mosc); 2014 Jul; 79(7):619-36. PubMed ID: 25108325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From bedside to cell biology: a century of history on lysosomal dysfunction.
    Coutinho MF; Matos L; Alves S
    Gene; 2015 Jan; 555(1):50-8. PubMed ID: 25275857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.